Icon

SANDOSTATIN (nda019667)- (EQ 0.05MG BASE/ML,EQ 0.1MG BASE/ML,EQ 0.5MG BASE/ML,EQ 0.2MG BASE/ML,EQ 1MG BASE/ML)

OCTREOTIDE ACETATE NOVARTIS
EQ 0.05MG BASE/ML,EQ 0.1MG BASE/ML,EQ 0.5MG BASE/ML,EQ 0.2MG BASE/ML,EQ 1MG BASE/ML
Yes No
2015-Nov-19 Expired
None None
None No
Sandostatin® (octreotide acetate) Injection is indicated to reduce blood levels of growth hormone (GH) and insulin growth factor-1 (IGF-1; somatomedin C) in acromegaly patients who have had inadequate response to or cannot be treated with surgical resection, pituitary irradiation, and bromocriptine mesylate at maximally tolerated doses. Sandostatin is indicated for the symptomatic treatment of patients with metastatic carcinoid tumors where it suppresses or inhibits the severe diarrhea and flushing episodes associated with the disease. Sandostatin is indicated for the treatment of the profuse watery diarrhea associated with VIP-secreting tumors.
14 0 12
Total Other Developers 20
Drugs with Suitability No
EQ 0.05MG BASE/ML ** ** - - 3
EQ 0.1MG BASE/ML ** ** - - -
EQ 0.5MG BASE/ML ** ** - - -
EQ 0.2MG BASE/ML ** ** - - -
EQ 1MG BASE/ML ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 10
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** ************* *********** *** *********** ***** ****** ***** ***, *****, - *****, ***** (***) ***
****** ******** ****** *** ******* ******* *********** *-**, **, ***, **, **, **, **, ** & *-**, ****, ******* ****** ***** *****, ******, *****, ***** & *** ******, ***** (***) ***
****** ********* **** *** ********* **** ***, *** *********** **** *. **** ****** **** ***** ********* ******, ******* ****, ******** (**) *****, ****** ****** (***) ***
****** ***** ****** *** ***** ****** ******* *********** **** **: **-**, **, **, **-**, **. **. ***, ***, *** & ***, ***** ***, *****, ************ *******, ********** ******, ********** ********, *********, ********* ******, ***** (***) ***
****** ********* **** *** ********* **** ***, *** *********** **** *. **** ****** **** ***** ********* ******, ******* ****, ******** (**) *****, ****** ****** (***) ***
****** ******** ****** *** ******* ******* *********** *-**, **, ***, **, **, **, **, ** & *-**, ****, ******* ****** ***** *****, ******, *****, ***** & *** ******, ***** (***) ***
****** ***** ****** *** ***** ****** ******* *********** **** **: **-**, **, **, **-**, **. **. ***, ***, *** & ***, ***** ***, *****, ************ *******, ********** ******, ********** ********, *********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.